Clinical leaders are able to easily customize workflows, then seamlessly disseminate protocols to frontline providers. Clinical Pathways are interactive decision trees with embedded links to clinical orders. AgileMD now has more than 4000 pathways live across emergency medicine, hospital medicine, surgery, oncology and primary care. 

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

Meplis helps organizations in all Life Science segments by offering patient and HCP engagement solutions configured from the Meplis modular white-label B2B SaaS technologies that combine rich content formats, support systems, connectivity, AI, intelligent insights, and integrations.

Outpatient patient engagement combining patient monitoring, personalized education, embedded social networks, private messaging, call & appointment scheduling, gamification 

White-label modular B2B SaaS with custom integration capabilities. Platforms are launched as web portals and mobile apps (Android / iOS)